Sanofi (SNY) Revenue (2009 - 2026)
Sanofi (SNY) posted Revenue of $13.5 billion for Q2 2026, up 9.56% sequentially from $12.3 billion in Q1 2026, and up 19.16% YoY from $11.3 billion in Q2 2025.
Sanofi (SNY) Revenue (2009 - 2026) Analysis & Trends
Sanofi has reported Revenue for 18 years, with the latest figure at $13.5 billion in Q2 2026.
- Quarterly Revenue rose 19.16% year-over-year to $13.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $53.6 billion (up 27.72% YoY) and the FY2025 annual result came in at $50.8 billion, up 15.68% from the prior year.
- Revenue improved to $13.5 billion in Q2 2026 per SNY's latest filing, from $12.3 billion in the prior quarter.
- Over five years, Revenue peaked at $40.7 billion in Q4 2023 and troughed at -$10.0 billion in Q4 2025.
- A 5-year average of $14.3 billion and a median of $11.1 billion in 2023 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 183.03% in 2025, down 245.37% in 2025.
- Over 5 years, Revenue stood at $32.9 billion in 2022, then advanced by 23.58% to $40.7 billion in 2023, then plunged by 83.1% to $6.9 billion in 2024, then plunged by 245.37% to -$10.0 billion in 2025, then surged by 234.87% to $13.5 billion in 2026.
- According to Business Quant data, Revenue over the past three periods registered $13.5 billion, $12.3 billion, and -$10.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.51 Bn | 632.75 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.67 Bn | 464.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 378.00 Bn | 370.86 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 303.24 Bn | 295.55 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.85 Bn | 252.95 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 236.64 Bn | 222.65 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 182.27 Bn | 179.09 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 159.46 Bn | 147.76 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 106.20 Bn | 102.03 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Sanofi | 55.06 Bn | 47.68 Bn | 10.79 Bn | 13.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.48 Bn |
| Mar 31, 2026 | 12.30 Bn |
| Dec 31, 2025 | -9.99 Bn |
| Sep 30, 2025 | 37.79 Bn |
| Jun 30, 2025 | 11.31 Bn |
| Mar 31, 2025 | 10.41 Bn |
| Dec 31, 2024 | 6.88 Bn |
| Sep 30, 2024 | 13.35 Bn |
| Jun 30, 2024 | 10.15 Bn |
| Mar 31, 2024 | 9.70 Bn |
| Dec 31, 2023 | 40.69 Bn |
| Sep 30, 2023 | 13.02 Bn |
| Jun 30, 2023 | 10.85 Bn |
| Mar 31, 2023 | 10.97 Bn |
| Dec 31, 2022 | 32.93 Bn |
| Sep 30, 2022 | 12.59 Bn |
| Jun 30, 2022 | 10.79 Bn |
| Mar 31, 2022 | 10.86 Bn |
| Dec 31, 2021 | 31.76 Bn |
| Sep 30, 2021 | 12.30 Bn |